Yuko Okada
Overview
Explore the profile of Yuko Okada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
739
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Minoura Y, Yokoyama K, Okada Y, Fukuda S, Kumagai H
Pediatr Int
. 2025 Feb;
67(1):e15880.
PMID: 39911100
No abstract available.
2.
Dofuku M, Yano T, Yokoyama K, Okada Y, Kumagai H, Tajima T, et al.
J Pediatr Gastroenterol Nutr
. 2025 Jan;
80(3):408-416.
PMID: 39760314
Objectives: Patients with Peutz-Jeghers syndrome (PJS) require continuous medical management throughout their lives. However, few case series regarding the clinical course, polyp surveillance, and treatment, including endoscopic ischemic polypectomy (EIP)...
3.
Okada Y, Kanno A, Sano N, Hashimoto Y, Yokoyama K, Kumagai H, et al.
Pediatr Int
. 2024 Jul;
66(1):e15772.
PMID: 38978179
No abstract available.
4.
Yamada T, Sugimoto H, Hironaka K, Morita Y, Miura H, Otowa-Suematsu N, et al.
J Endocr Soc
. 2024 Apr;
8(6):bvae067.
PMID: 38633895
Context: Sodium-glucose cotransporter 2 (SGLT2) inhibitors lower blood glucose levels by promoting urinary glucose excretion, but their overall effects on hormonal and metabolic status remain unclear. Objective: We here investigated...
5.
Hemorrhagic duodenal ulcer as a rare complication prior to antiplatelet therapy for Kawasaki disease
Hashimoto Y, Kumagai H, Okada Y, Seki M, Yasuyuki N, Yamagata T, et al.
Pediatr Int
. 2023 Sep;
65(1):e15628.
PMID: 37658613
No abstract available.
6.
Yamasaki R, Okada Y, Iizumi H, Ito A, Fukuda K, Okamoto I
J Org Chem
. 2023 Apr;
88(9):5704-5712.
PMID: 37094254
Although transamidation of amides generally requires metals, additives, or harsh conditions, we present here a facile transamidation of -cyano amides with various amines at ambient temperature without any additive. -cyano...
7.
Fujita Y, Kamitani F, Yamamoto M, Fukuoka H, Hirota Y, Nishiyama N, et al.
J Endocr Soc
. 2023 Jan;
7(3):bvad002.
PMID: 36694808
Context: The occurrence of multiple endocrinopathies due to immune checkpoint inhibitors (ICIs) is a relatively common adverse event. However, the occurrence of a combination of hypophysitis and type 1 diabetes...
8.
Suzuki M, Urai S, Fukuoka H, Hirota Y, Yamamoto M, Okada Y, et al.
J Diabetes Investig
. 2022 Apr;
13(9):1585-1595.
PMID: 35470583
Aims/introduction: The bone mineral density in patients with type 1 diabetes mellitus is reduced due to impaired insulin secretion. However, it is unclear whether the rate of bone mineral density...
9.
Takai T, Okada Y, Takebe R, Nakamura T
Diabetol Int
. 2022 Jan;
13(1):272-279.
PMID: 35059263
Introduction: Diabetic ketoacidosis (DKA) is an acute life-threatening complication in patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). Causes, underlying pathophysiology, and mortality differ significantly...
10.
Takeuchi T, Hirota Y, Nakagawa Y, Matsuoka A, Hamaguchi T, Okada Y, et al.
Diabetol Int
. 2022 Jan;
13(1):226-231.
PMID: 35059259
Patients with diabetes mellitus having insulin antibodies (InsAb) with properties of high binding capacity and low affinity, which are observed in insulin autoimmune syndrome (IAS), are known to have greater...